Navigation Links
LSUHSC's Rodriguez receives cancer immunotherapy Presidential Award
Date:11/12/2013

New Orleans, LA Paulo C. Rodriguez, PhD, Assistant Professor Research of Microbiology, Immunology & Parasitology at LSU Health Sciences Center New Orleans' Stanley S. Scott Cancer Center, was selected as the 2013 recipient of the Presidential Award by the Society for Immunotherapy of Cancer (SITC). Established in 1991, the SITC Presidential Award is the most prestigious of the young investigator awards in immunotherapy, which are based upon excellence in quality of research and presentation, the strength of results and methods, and whether the reported research significantly advances the field of cancer immunotherapy. From among four candidates, the SITC leadership selects the young investigator making the most outstanding oral presentation of his/her work at the annual meeting to receive its Presidential Award. The award was presented to Dr. Rodriguez during the SITC 28th Annual Meeting, November 7 - 10, 2013.

Dr. Rodriguez's award-winning research identified a potential new therapeutic approach to make T cells, key cells of the immune system, resistant to the suppressive effect caused by tumors. T cells are a type of white blood cell that help the body fight infection and diseases, including cancer. Although it is known that cancer cells inactivate T cells, allowing tumors to grow unchecked, understanding how to prevent and overcome this process has been limited. Dr. Rodriguez studied the role of Notch, a family of receptors, in the suppression of T cell responses in cancer. By manipulating Notch-1 in transgenic mice with cancer, he found that increasing active Notch-1 levels in tumor-specific T cells dramatically enhanced their anti-tumor activity and rendered them resistant to immune suppression caused by tumors. Dr. Rodriguez's findings suggest that Notch-1 may be an effective new therapeutic approach for T cell-based immunotherapy.

In addition to two National Institutes of Health grants, Dr. Rodriguez's research is also supported by the Copeland/LSUHSC Partnership in Viruses, Cancer and Immunotherapy.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related medicine news :

1. Dr. Dirk Rodriguez Recommends Obesity Surgery for Teens
2. Nemours receives Dept. of Defense award to study physicians maintenance of optimal clinical program
3. Countervail Corporation Receives Additional $5.4 Million from BARDA For Continued Development of Medical Countermeasure to Nerve Agents
4. Penn Medicine receives award from Patient-Centered Outcomes Research Institute
5. Woman with Type I Diabetes Receives Life-Changing Grant from Core Fitness Solution
6. Living Well Assisted Living at Home Receives Artwork for Display
7. WellRight Corporate Wellness Software Receives Funding
8. Independent Naturopathic Clinic Receives Groundbreaking Research Grant: Partners with Global Pharmaceutical Company to Study Relief of Cancer Drug Side Effects
9. California receives A grade on Preterm Birth Report Card
10. MU receives $1.1 million training grant to increase diversity in biomedical sciences
11. The Lymphedema Toolbox, a Physical Therapy Continuing Education Course and Patient Information Management Tool Receives State Approval in CA, FL, TX, NV, NY, DC and WA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... 2017 , ... Guide to FDA and EU Medical Device Regulations: 2017 Edition, ... of the Atlantic devicemakers do business, this fully updated and expanded guide keeps them ... to the full text of the FDA’s regulations in 21 CFR Parts 800 to ...
(Date:6/28/2017)... ... ... David B. Sosin, a founding partner at the law firm Sosin, Arnold ... President for the Illinois State Bar Association , in accordance with the organization’s rules ... 2016 following a state-wide election and served in that capacity for the past year prior ...
(Date:6/28/2017)... Columbia (PRWEB) , ... June 28, 2017 , ... ... (FSE: ZEON) is pleased to announce that a two year study conducted by ... Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As a ...
(Date:6/28/2017)... ... June 28, 2017 , ... The Dianne ... the greater Cincinnati metropolitan area, is teaming up with the local chapter of ... children receiving treatment in nearby hospitals. , Ronald McDonald House of Greater Cincinnati, ...
(Date:6/27/2017)... ... 27, 2017 , ... Harbour , a DAO (decentralized autonomous organization) that ... has released their technical specifications . , 2017 has seen an explosion of ... for determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: